BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 1191554)

  • 21. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets.
    Widmer K; Moake JL; Kent CJ; Yeo YY; Reynolds JP
    J Lab Clin Med; 1976 Jan; 87(1):49-57. PubMed ID: 1245783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructure of clots during isometric contraction.
    Cohen I; Gerrard JM; White JG
    J Cell Biol; 1982 Jun; 93(3):775-87. PubMed ID: 6889599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Structural-functional organization of hemostatic clots].
    Kozlov VK; Chepurov AK
    Biull Eksp Biol Med; 1978 Feb; 85(2):132-6. PubMed ID: 630079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of reduced glutathione on platelet functions.
    Matsuda S; Ikeda Y; Aoki M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1979 Dec; 42(4):1324-31. PubMed ID: 542937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides.
    Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ
    Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure.
    Jalal MM; Whyte CS; Coxon FP; Mutch NJ
    Platelets; 2023 Dec; 34(1):2206921. PubMed ID: 37139869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of teniposide on platelet functions in vitro.
    Kubisz P; Seghier F; Dobrotorá M; Stasko J; Cronberg S
    Thromb Res; 1995 Jan; 77(2):145-8. PubMed ID: 7740506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural characteristics of fibrin clots from canine and feline platelet concentrates activated with calcium gluconate or calcium gluconate plus batroxobin.
    Silva RF; Carmona JU; Rezende CM
    BMC Vet Res; 2013 Apr; 9():77. PubMed ID: 23587176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructure of the interaction between human platelets and polymerizing fibrin within the first minutes of clot formation.
    Morgenstern E; Ruf A; Patscheke H
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):543-6. PubMed ID: 2133232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction.
    Rooney MM; Farrell DH; van Hemel BM; de Groot PG; Lord ST
    Blood; 1998 Oct; 92(7):2374-81. PubMed ID: 9746777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin ablates force development during platelet mediated clot retraction.
    Carr ME; Carr SL; Greilich PE
    Thromb Haemost; 1996 Apr; 75(4):674-8. PubMed ID: 8743198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemostatic clot formation at anastomosis of synthetic venous graft in defibrinogenated dogs: a scanning electron microscopic study.
    Ishimaru S; Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Haemost; 1981 Jun; 45(3):276-81. PubMed ID: 7025342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Phosphoinositides in Rabbit Platelets during Clot Formation. Comparison of Platelets Stimulated by ADP or by Thrombin in the Presence of Polymerising Fibrin.
    Vickers JD; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Platelets; 1990; 1(4):199-204. PubMed ID: 21043948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 May; 71(5):1310-20. PubMed ID: 3359044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin-induced release of platelet serotonin.
    Orloff KG; Michaeli D
    Am J Physiol; 1976 Aug; 231(2):344-50. PubMed ID: 961885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.